AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2018
May 15, 2018
30583_dirs_2018-05-14_367bb51c-1921-40dc-8873-eff292bba7a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2018-04-30
Reporting Person: Mueller Brian (SVP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-04-30 | Common Stock | A | 287 | $68.782 | Acquired | 17846 | Direct |
| 2018-05-10 | Common Stock | S | 2450 | $89.500 | Disposed | 15396 | Direct |
Footnotes
F1: Represents shares acquired by the reporting person on April 30, 2018, pursuant to the issuer's Employee Stock Purchase Plan.
F2: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19